In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Cigna’s current price at $293.83 is significantly below the PERT-weighted fair value of $1,091.65, indicating substantial undervaluation and upside potential. High-confidence DCF and Monte Carlo analyses suggest robust intrinsic value with low downside risk, despite moderate financial health and growth scores. Elevated volatility highlights investment risk alongside attractive return prospects.